Given that the lockdown measures taken so as to diminish the dissemination of the COVID-19 pandemic are likely to create major mental disorders such as obsessive-compulsive disorder (OCD), the present study was conducted aiming to evaluate the prevalence of OCD and cognitive errors among young people during the outbreak of coronavirus disease 2019. The present study is a descriptive, cross-sectional study in which a total of 150 young people aged 13 to 19 were randomly included. Maudsley Obsessive-Compulsive Inventory Questionnaire (MOCI) and Cognitive Error Questionnaire (CEQ) were completed, and then their results were analyzed by SPSS 22 software. The results revealed that 67.3% of the subjects who were evaluated may have demonstrated OCD symptomatology. The prevalence of obsessive-compulsive disorder symptoms in women was slightly higher than in men (72.1 compared to 60.3%). Likewise, the test results indicated that there was a significant difference between obsessive-compulsive disorder symptom in men and women ( p = .001). There was also a significant difference between the two groups with OCD symptoms and without OCD symptoms in all the components of cognitive errors ( p = .001). To the authors’ best of knowledge, this is the first study that has evaluated OCD symptoms at the time of COVID-19 prevalence. The findings suggest the need to enhance the prevention of relapse during social restrictions as well as to develop other strategies including online consultation and digital psychiatric management.
Background Apart from infecting a large number of people around the world and causing the death of many people, the COVID-19 pandemic seems to have changed the healthcare processes of other diseases by changing the allocation of health resources and changing people’s access or intention to healthcare systems. Objective To compare the incidence of endpoints marking delayed healthcare seeking in medical emergencies, before and during the pandemic. Methods Based on a PICO model, medical emergency conditions that need timely intervention was selected to be evaluated as separate panels. In a systematic literature review, PubMed was quarried for each panel for studies comparing the incidence of various medical emergencies before and during the COVID-19 pandemic. Markers of failure/disruption of treatment due to delayed referral were included in the meta-analysis for each panel. Result There was a statistically significant increased pooled median time of symptom onset to admission of the acute coronary syndrome (ACS) patients; an increased rate of vasospasm of aneurismal subarachnoid hemorrhage; and perforation rate in acute appendicitis; diabetic ketoacidosis presentation rate among Type 1 Diabetes Mellitus patients; and rate of orchiectomy among testicular torsion patients in comparison of pre-COVID-19 with COVID-19 cohorts; while there were no significant changes in the event rate of ruptured ectopic pregnancy and median time of symptom onset to admission in the cerebrovascular accident (CVA) patients. Conclusions COVID-19 has largely disrupted the referral of patients for emergency medical care and patient-related delayed care should be addressed as a major health threat.
Coronavirus disease 2019 , a new type and rapidly spread viral pneumonia, is now producing an outbreak of pandemic proportions. The clinical features and laboratory results of different age groups are different due to the general susceptibility of the disease. The laboratory findings of COVID-19 in pregnant women are also conflicting. Para-clinical investigations including laboratory tests and radiologic findings play an important role in early diagnosis and treatment monitoring of severe acute respiratory syndrome and coronavirus-2 (SARS-CoV-2). The majority of previous reports on the SARS-CoV-2 laboratory results were based on data from the general population and limited information is available based on age difference and pregnancy status. This review aimed to describe the COVID-19 laboratory findings in neonates, children, adults, elderly and pregnant women altogether for the first time.The most attracting and reliable markers of COVID-19 in patients were: normal C-reactive protein (CRP) and very different and conflicting laboratory results regardless of clinical symptoms in neonates, normal or temporary elevated CRP, conflicting WBC count results and procalcitonin elevation in children, lymphopenia and elevated lactate dehydrogenase (LDH) in adult patients, lymphopenia and elevated CRP and LDH in the elderly people and high CRP, leukocytosis and elevated neutrophil ratio in pregnant women.
Purpose: Both type 2 diabetes mellitus (T2DM) and hypertension are regarded as lifethreatening diseases known to be risk factors for vascular diseases. They may be associated with the increased risk of cognitive impairment (CI), although there are conflicting data relating hypertension to the risk of CI. Therefore, this study aimed to explore the probable association between hypertension and CI in patients with T2DM. Patients and Methods: This cross-sectional study assessed the degree of CI of a total of 350 patients with T2DM using the Mini-Mental State Examination (MMSE). In clinical examinations, the mean of the first, second, and third measurements of systolic and diastolic blood pressure (SBP and DBP) was recorded. Results: The mean of subjects' MMSE scores was 25.48 ± 3.73. Additionally, the means of SBPSs and DBPs were found to be 118.50 ± 17.27 and 73.47 ± 10.25 mmHg, respectively. The Spearman correlation coefficient showed a mild, significant, negative correlation between MMSE scores and those of SBP (r = −0.199, p <0.001) and DBP (r = −0.233, p <0.001). Accordingly, a 1-unit increase in one's SBP would lead to a significant rise in mild CI (2.8%) in comparison with subjects who have normal CIs. However, it was shown that if one's DBP increased by 1 unit, the odds of mild CI occurring would increase significantly by 6.7% compared with those who have normal CIs. Conclusion: The present findings revealed that hypertension might be related to the development of CI in people with a diabetic condition, thus emphasizing the fact that the prevention and treatment of these highly prevalent diseases assume the utmost significance.
Background: Diabetes mellitus is a chronic, destructive metabolic disease. One of the factors that can affect the mental and physical health of diabetic patients is spiritual intelligence and emotional intelligence. Objectives: This study aimed to investigate the relationship between spiritual intelligence and emotional intelligence in patients with type 2 diabetes. Methods: This descriptive-correlational study was performed on 100 patients with type 2 diabetes who referred to the Kermanshah Diabetes Research Center and selected by the convenient sampling method. In order to determine the spiritual intelligence in diabetic patients, the King's Spiritual Intelligence was used while Petrides & Furnham Inventory of Emotional Intelligence was applied to evaluate emotional intelligence. In order to analyze the data, SPSS version 22 was used. Results: The mean age of the patients was 39.97 ± 11.8. The mean score of spiritual intelligence was 52.10 ± 18.05 and the mean score of emotional intelligence was 127.62 ± 23.88. The results showed that there was a positive significant difference between spiritual intelligence and emotional intelligence and its subscales in patients with type 2 diabetes (P > 0.001). Conclusions: It can be concluded that spiritual intelligence and emotional intelligence can complement each other in order to increase diabetes self-management and adaptive mechanisms in patients. The more the patient is against wrong behaviors of others and trusts in God for his/her tasks, the better the individual can manage his/her daily activities in life and provide a context for emotional intelligence development.
Introduction: Caregivers play a critical role in health management of patients with chronic diseases. Caregiving is associated with experiencing different emotional and psychological problems. Objective: This study aims to determine the relationship between caregiver burden and cognitive function in adult patients with Type 2 Diabetes (T2D). Materials and Methods: In this cross-sectional study, 215 family caregivers of adult patients with T2D were selected by a systematic random sampling method. A socio-demographic form, the Caregiver Burden Inventory (CBI), and the Mini-Mental State Examination (MMSE) were used for data collection. Data were analyzed using Kruskal-Wallis test, Spearman’s rho correlation test. The multinomial logistic regression model was used to examine the power of Cognitive Impairment (CI) in predicting the caregiver burden. P<0.05 was considered as the statistically significance level. Results: The mean age of caregivers and patients were 48±9 and 52±2 years, respectively. The mean score of CBI was 24.57±18.2, indicating a moderate level of caregiver burden. The mean score of MMSE was 25.25±3.6, indicating a mild CI in patients. Caregiver burden showed a significant correlation with cognitive function (r=-0.336, 95% CI; 0.53–0.89, P=0.001) such that the decreased CI was associated with an increase in total caregiver burden (r=-0.348, 95% CI; 0.43–0.87, P=0.001). The regression results showed that the CI levels were not predictors of caregiver burden severity. Conclusion: The CI of patients with T2D may affect their caregivers’ burden. Therefore, assessing the cognitive function of these patients can help healthcare providers conduct interventions to enhance the caregivers’ quality of life.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.